STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALUR
  4. [EFFECT] ALLURION TECHNOLOGIES, INC. SEC Filing

[EFFECT] ALLURION TECHNOLOGIES, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 16, 2026 5:30 P.M.
Form: S-3
CIK: 0001964979
Company Name: ALLURION TECHNOLOGIES, INC.
File Number: 333-292660

Source: View Original Filing on SEC EDGAR

ALLURION TECHNOLOGIES INC

OTC:ALUR

View ALUR Stock Overview →

ALUR Rankings

#6400 Ranked by Market Cap
N/A Ranked by Dividends
#41 Ranked by Short %Change

ALUR Latest News

Mar 11, 2026
Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy
Mar 2, 2026
Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE
Feb 24, 2026
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
Feb 23, 2026
Allurion Receives U.S. FDA Approval
Feb 3, 2026
Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices

ALUR Latest SEC Filings

Mar 2, 2026
[SCHEDULE 13D/A] ALLURION TECHNOLOGIES, INC. Amended Major Shareholder Report
Mar 2, 2026
[8-K] ALLURION TECHNOLOGIES, INC. Reports Material Event
Feb 25, 2026
[8-K] ALLURION TECHNOLOGIES, INC. Reports Material Event
Feb 23, 2026
[8-K] ALLURION TECHNOLOGIES, INC. Reports Material Event
Jan 16, 2026
[424B3] ALLURION TECHNOLOGIES, INC. Prospectus Filed Pursuant to Rule 424(b)(3)

ALUR Stock Data

10.03M
11.50M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NATICK